Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment.

Erika E Ramsdale Mostafa R S MohamedVeronica YuEthan OttoKatherine JubaHala AwadKiran MoorthiSandy PlumbAmita PatilNicholas VogelzangElie DibSupriya Mohile

Published in: The oncologist (2022)

In a cohort of vulnerable older adults with advanced cancer starting treatment, polypharmacy, PIM, and potential DDI/DCI are very common. Nonprescription medications are frequently PIMs and/or involved in potential DDI/DCI.

Keyphrases

advanced cancer
palliative care
physical activity
adverse drug
combination therapy
risk assessment
climate change
replacement therapy